Number of the records: 1
HIV를 치료하는데 사용되는 퀴나졸린 유도체
- 1.
SYSNO ASEP 0552130 Document Type P - Patent R&D Document Type Patent or other outcome protected by special legislation Title HIV를 치료하는데 사용되는 퀴나졸린 유도체 Title Quinazoline derivatives used to treat HIV Author(s) Jansa, Petr (UOCHB-X) RID
Šimon, Petr (UOCHB-X) ORCID
Lansdon, E. (US)
Hu, Y. E. (US)
Baszczyňski, Ondřej (UOCHB-X) RID, ORCID
Dejmek, Milan (UOCHB-X) RID, ORCID
Mackman, R. (US)Year of issue 2021 Possible third party use of the result A - Pro využití výsledku jiným subjektem je vždy nutné nabytí licence Royalty requested A - Poskytovatel licence požaduje licenční poplatek Patent no. or utility model no. or industrial design no. KR102288855 Date of the patent acceptance 11.08.2021 Name of the patent owner Gilead Sciences, Inc. - Ústav organické chemie a biochemie AV ČR, v. v. i Code of the issuer name KR001 - Korean Intellectual Property Office (KIPO) Daejeon Metropolitan City Current use B - Patent je využíván na základě uzavřené licenční smlouvy mezi vlastníkem a uživatelem Language kor - Korean Keywords quinazoline ; reverse transcriptase ; antiviral ; NNRTI OECD category Organic chemistry Institutional support UOCHB-X - RVO:61388963 Annotation 화학식 I의 화합물 및 그의 호변이성질체 및 제약 염, 이러한 화합물을 함유하는 조성물 및 제제, 및 이러한 화합물을 사용 및 제조하는 방법이 본원에 기재된다. 화학식 I Description in English Described herein are compounds of formula (I) and their tautomers and pharmaceutical salts, compositions and formulations containing such compounds, and methods of using and preparing such compounds. Workplace Institute of Organic Chemistry and Biochemistry Contact asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Jana Procházková, Tel.: 220 183 418 Year of Publishing 2022 Electronic address https://worldwide.espacenet.com/patent/search/family/055305044/publication/KR102288855B1?q=KR2288855
Number of the records: 1